Prostate Cancer

Blacks with Recurrent Prostate Cancer More Likely To Regret Treatment

Blacks with Recurrent Prostate Cancer More Likely To Regret Treatment

By

Racial differences in prostate cancer (PCa) treatment regret more pronounced among those without sexual problems.

Androgen Deprivation Therapy (ADT) Raises Heart-Related Death Risk

Androgen Deprivation Therapy (ADT) Raises Heart-Related Death Risk

But overall risk of heart-related death risk from prostate cancer treatment is small, researchers say.

Men with More Female Partners Have Lower Prostate Cancer (PCa) Risk

Men with More Female Partners Have Lower Prostate Cancer (PCa) Risk

Men who have slept with more than 20 female partners are less likely to develop aggressive prostate cancer (PCa).

Prostate Cancer Radiotherapy Outcomes Worse in Smokers

Prostate Cancer Radiotherapy Outcomes Worse in Smokers

By

Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.

Eating More Tomatoes Lowers Prostate Cancer (PCa) Risk

Eating More Tomatoes Lowers Prostate Cancer (PCa) Risk

Consuming ten portions of tomatoes a week can lower the risk of prostate cancer.

Aspirin May Lower Non-Metastatic Prostate Cancer Mortality

Aspirin May Lower Non-Metastatic Prostate Cancer Mortality

Significant association observed for high-risk prostate cancers with no difference according to daily dose.

Vitamin D May Suppress Prostate Tissue Inflammation

Vitamin D May Suppress Prostate Tissue Inflammation

Vitamin D may be able to suppress inflammation in prostate tissue by boosting expression of the GDF-15 gene.

Prostate Cancer Risk Not Linked to Fertility

Prostate Cancer Risk Not Linked to Fertility

By

Fathering of dizygotic twins, a marker of high fertility, was not associated with increased risk of prostate cancer.

ConfirmMDx Genetic Test Identifies Prostate Cancer Aggressiveness

ConfirmMDx Genetic Test Identifies Prostate Cancer Aggressiveness

New data confirms that ConfirmMDx, an epigenetic assay, is able to accurately identify prostate cancer aggressiveness

Testosterone Replacement Therapy (TRT) May Promote Prostate Tumor Growth

Testosterone Replacement Therapy (TRT) May Promote Prostate Tumor Growth

Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.

High Cholesterol Linked with Prostate Cancer Recurrence

High Cholesterol Linked with Prostate Cancer Recurrence

Findings suggest that normalization of blood fats may reduce risk of prostate cancer.

Prostate Cancer Death Risk Higher After External Beam Radiation Therapy (EBRT) than Surgery

Prostate Cancer Death Risk Higher After External Beam Radiation Therapy (EBRT) than Surgery

By

Mortality was greater with external beam radiotherapy across treatment-specific nomograms for predicting biochemical recurrence.

In Black Prostate Cancer Patients, Active Surveillance Safe

In Black Prostate Cancer Patients, Active Surveillance Safe

By

Researchers confident in this approach because candidates for active surveillance are a heavily screened population.

Gene Can Predict Aggressive Prostate Cancer at Diagnosis

Gene Can Predict Aggressive Prostate Cancer at Diagnosis

A biomarker present on the KLK3 gene can predict which GS7 prostate cancer patients will be more aggressive.

Robotic Prostate Cancer Surgery Widely Used

Robotic Prostate Cancer Surgery Widely Used

By

Growth in robot-assisted radical prostatectomy (RARP) use especially pronounced among surgeons at urban hospitals.

Smoking Raises Prostate Cancer Death Risk

Smoking Raises Prostate Cancer Death Risk

By

Meta-analysis shows that the risk is increased 20% with each 20 cigarettes smoked per day.

Prostate Biopsy Complication Rates Increasing

Prostate Biopsy Complication Rates Increasing

By

Urologic complications requiring hospital admission grew from 3.6% in 2000 to 3.9% in 2008, largely because of infections.

Radical Prostatectomy Outcomes Similar for Obese, Non-Obese

Radical Prostatectomy Outcomes Similar for Obese, Non-Obese

By

Outcomes of robot-assisted radical prostatectomy in obese patients are mostly comparable to non-obese patients.

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

By

Men who had PSA relapse after receiving post-radical surgery salvage radiation therapy had a median overall survival of nearly 14 years.

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

Early Adjuvant Radiotherapy Benefits Selected Prostate Cancer Patients

By

Radiotherapy given within 6 months of radical prostatectomy reduces cancer-specific mortality in men with highly aggressive disease.

Has the proportion of your patients undergoing prostate brachytherapy been declining?

Has the proportion of your patients undergoing prostate brachytherapy been declining?

By

Prostate cancer patients undergoing radical prostatectomy increased by double digits while those undergoing brachytherapy decreased.

Sexual Function Preserved in Prostate Cancer Combination Therapy

Sexual Function Preserved in Prostate Cancer Combination Therapy

High rates of preserved sexual function with combination beam plus brachytherapy.

Radical Prostatectomy Rates Rising

Radical Prostatectomy Rates Rising

By

Utilization rates jumped by double digits across prostate cancer risk groups from 2004 to 2011.

Male Pattern Baldness Linked with Prostate Cancer

Male Pattern Baldness Linked with Prostate Cancer

Men with male pattern baldness may face a higher risk of aggressive prostate cancer.

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

Statins Reduce Prostate Cancer Recurrence Risk After Radiotherapy

By

This benefit is not seen in patients who undergo radical prostatectomy, according to an updated meta-analysis.

Watchful Waiting Not Suitable for Black Men with Prostate Cancer

Watchful Waiting Not Suitable for Black Men with Prostate Cancer

Black prostate cancer patients more likely to develop aggressive disease earlier than white patients.

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

Aspirin Eases Genitourinary (GU) Toxicity from Prostate Cancer Radiotherapy

By

Low-dose aspirin decreased the likelihood of acute genitourinary toxicity in prostate cancer by 27%.

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

Genetic Variant May Predict Resistance to Prostate Cancer Drugs

By

Enzalutamide and abiraterone may not benefit men with metastatic castration-resistant prostate cancer who have AR-V7 in circulating tumor cells.

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

Men with Metabolic Aberrations Have Lower Prostate Cancer Risk

By

However, they are more likely to die from causes other than prostate cancer than men with normal metabolic levels.

FDA Approves New Indication for Enzalutamide

FDA Approves New Indication for Enzalutamide

By

The drug is now also approved for use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Sign Up for Free e-newsletters